Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Mills

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Cell Reports|October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityWenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanismsStephen Y Lai, Priya Koppikar, Sufi M Thomas, et al.
Nature Communications|September 13, 2023
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast CancerZinab O Doha, Xiaoyan Wang, Nicholas L Calistri, et al.
Nature Communications|December 22, 2018
Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Nature|August 10, 2018
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 responseGang Chen, Alexander C Huang, Wei Zhang, et al.
Nature|September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature|December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Cell Reports. Medicine|March 31, 2026
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanomaShiyou Wei, Yulan Deng, Jinho Lee, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Cell Reports|October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityWenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanismsStephen Y Lai, Priya Koppikar, Sufi M Thomas, et al.
Nature Communications|September 13, 2023
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast CancerZinab O Doha, Xiaoyan Wang, Nicholas L Calistri, et al.
Nature Communications|December 22, 2018
Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Nature|August 10, 2018
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 responseGang Chen, Alexander C Huang, Wei Zhang, et al.
Nature|September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature|December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Cell Reports. Medicine|March 31, 2026
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanomaShiyou Wei, Yulan Deng, Jinho Lee, et al.
Pageof 7